These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31733933)

  • 1. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study.
    Buikhuisen WA; Qayyum F; Armato SG; Baas P
    Lung Cancer; 2019 Dec; 138():139-140. PubMed ID: 31733933
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.
    Gudmundsson E; Labby Z; Straus CM; Sensakovic WF; Li F; Rose B; Cunliffe A; Kindler HL; Armato SG
    Eur Radiol; 2019 Feb; 29(2):682-688. PubMed ID: 29967955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).
    Armato SG; Nowak AK
    J Thorac Oncol; 2018 Jul; 13(7):1012-1021. PubMed ID: 29753121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine deprivation for ASS1-deficient mesothelioma.
    Burki TK
    Lancet Oncol; 2016 Oct; 17(10):e423. PubMed ID: 27622996
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma.
    Nowak AK; Brown C; Millward MJ; Creaney J; Byrne MJ; Hughes B; Kremmidiotis G; Bibby DC; Leske AF; Mitchell PLR; Pavlakis N; Boyer M; Stockler MR
    Lung Cancer; 2013 Sep; 81(3):422-427. PubMed ID: 23787063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT, RECIST, and malignant pleural mesothelioma.
    Nowak AK
    Lung Cancer; 2005 Jul; 49 Suppl 1():S37-40. PubMed ID: 15950799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
    van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
    Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.
    Laurie SA; Hao D; Leighl NB; Goffin J; Khomani A; Gupta A; Addison CL; Bane A; Seely J; Filion ML; Pond GR; Levine MN
    Lung Cancer; 2017 Feb; 104():65-69. PubMed ID: 28213002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.
    Vivoda Tomšič M; Bisdas S; Kovač V; Serša I; Šurlan Popovič K
    Cancer Imaging; 2019 Feb; 19(1):10. PubMed ID: 30813957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
    Kanemura S; Kuribayashi K; Funaguchi N; Shibata E; Mikami K; Doi H; Kitajima K; Hasegawa S; Nakano T
    Eur J Radiol; 2017 Jan; 86():92-98. PubMed ID: 28027772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of tumor response in malignant pleural mesothelioma.
    Ceresoli GL; Chiti A; Zucali PA; Cappuzzo F; De Vincenzo F; Cavina R; Rodari M; Poretti D; Lutman FR; Santoro A
    Cancer Treat Rev; 2007 Oct; 33(6):533-41. PubMed ID: 17764849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural mesothelioma in a young adult with no known exposure to asbestos.
    Espinosa Muñoz E; Ramírez Ocaña D; Gutiérrez Cardo AL
    Arch Bronconeumol; 2016 Dec; 52(12):615-616. PubMed ID: 27156205
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of new flex-rigid pleuroscopy in the diagnosis of malignant pleural mesothelioma.
    Ishii S; Ishii Y; Kaburagi T; Nakano T
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642855
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of bevacizumab in the treatment of malignant pleural mesothelioma.
    Brosseau S; Assoun S; Naltet C; Steinmetz C; Gounant V; Zalcman G
    Future Oncol; 2017 Dec; 13(28):2537-2546. PubMed ID: 29086616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
    Blomberg C; Nilsson J; Holgersson G; Edlund P; Bergqvist M; Adwall L; Ekman S; Brattström D; Bergström S
    Anticancer Res; 2015 May; 35(5):2493-501. PubMed ID: 25964522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of pleural epithelioid sarcoma of proximal type presenting as malignant pleural mesothelioma.
    Madsen GA; Rasmussen TR; Bærentzen S
    J Thorac Oncol; 2013 Oct; 8(10):e89-90. PubMed ID: 24457248
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease volumes as a marker for patient response in malignant pleural mesothelioma.
    Labby ZE; Nowak AK; Dignam JJ; Straus C; Kindler HL; Armato SG
    Ann Oncol; 2013 Apr; 24(4):999-1005. PubMed ID: 23144443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual presentation and location pleural malignant mesothelioma.
    Kumar A; Carcano C; Hadeh A; Lilenbaum R
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?
    Addeo A; Buffoni L; Di Maio M
    JAMA Oncol; 2017 Sep; 3(9):1170-1171. PubMed ID: 28114625
    [No Abstract]   [Full Text] [Related]  

  • 20. Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases.
    Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE
    Lung Cancer; 2004 Jan; 43(1):71-4. PubMed ID: 14698539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.